no code implementations • 5 Apr 2024 • Tengfei Ma, Xiang Song, Wen Tao, Mufei Li, Jiani Zhang, Xiaoqin Pan, Jianxin Lin, Bosheng Song, Xiangxiang Zeng
Knowledge graph completion (KGC) aims to alleviate the inherent incompleteness of knowledge graphs (KGs), which is a critical task for various applications, such as recommendations on the web.
1 code implementation • 20 Mar 2024 • Peng Zhou, Jianmin Wang, Chunyan Li, Zixu Wang, Yiping Liu, Siqi Sun, Jianxin Lin, Longyue Wang, Xiangxiang Zeng
While various models and computational tools have been proposed for structure and property analysis of molecules, generating molecules that conform to all desired structures and properties remains a challenge.
1 code implementation • 28 Dec 2023 • Geyan Ye, Xibao Cai, Houtim Lai, Xing Wang, Junhong Huang, Longyue Wang, Wei Liu, Xiangxiang Zeng
Recently, the impressive performance of large language models (LLMs) on a wide range of tasks has attracted an increasing number of attempts to apply LLMs in drug discovery.
no code implementations • 9 Dec 2023 • Tengfei Ma, Yujie Chen, Wen Tao, Dashun Zheng, Xuan Lin, Patrick Cheong-lao Pang, Yiping Liu, Yijun Wang, Bosheng Song, Xiangxiang Zeng
By maximizing the mutual information between the reliable structure and smoothed semantic relations, DenoisedLP emphasizes the informative interactions for predicting relation-specific links.
no code implementations • 3 Aug 2023 • Jianxin Lin, Peng Xiao, Yijun Wang, Rongju Zhang, Xiangxiang Zeng
To address these issues, we propose a new method called DiffColor that leverages the power of pre-trained diffusion models to recover vivid colors conditioned on a prompt text, without any additional inputs.
1 code implementation • 8 Jun 2023 • Xuan Lin, Lichang Dai, Yafang Zhou, Zu-Guo Yu, Wen Zhang, Jian-Yu Shi, Dong-Sheng Cao, Li Zeng, Haowen Chen, Bosheng Song, Philip S. Yu, Xiangxiang Zeng
Recent advances and achievements of artificial intelligence (AI) as well as deep and graph learning models have established their usefulness in biomedical applications, especially in drug-drug interactions (DDIs).
1 code implementation • 13 Mar 2023 • Shan Tang, Shanjun Mao, Yangyang Chen, Falong Tan, Lihua Duan, Cong Pian, Xiangxiang Zeng
Many methods adopt gut microbiota to solve it, but few of them simultaneously take into account the complex interactions and individual heterogeneity of gut microbiota, which are two common and important issues in genetics and intestinal microbiology, especially in high-dimensional cases.
no code implementations • 17 Dec 2022 • Xin Xia, Yansen Su, ChunHou Zheng, Xiangxiang Zeng
However, efficient search for optimized molecules satisfying several properties with scarce labeled data remains a challenge for machine learning molecule optimization.
no code implementations • 28 Mar 2022 • Zimeng Li, Shichao Zhu, Bin Shao, Tie-Yan Liu, Xiangxiang Zeng, Tong Wang
Drug-drug interaction (DDI) prediction provides a drug combination strategy for systemically effective treatment.
no code implementations • 8 Feb 2022 • Xiaoqin Pan, Xuan Lin, Dongsheng Cao, Xiangxiang Zeng, Philip S. Yu, Lifang He, Ruth Nussinov, Feixiong Cheng
Drug development is time-consuming and expensive.
1 code implementation • CIKM '21: Proceedings of the 30th ACM International Conference on Information & Knowledge Management 2021 • Hui Wang, Wan-Lei Zhao, Xiangxiang Zeng, Jianye Yang
In this paper, NN-Descent has been redesigned to adapt to the GPU architecture.
1 code implementation • 20 Jul 2021 • Shuting Jin, Xiangxiang Zeng, Wei Huang, Feng Xia, Changzhi Jiang, Xiangrong Liu, Shaoliang Peng
The Corona Virus Disease 2019 (COVID-19) belongs to human coronaviruses (HCoVs), which spreads rapidly around the world.
1 code implementation • 29 Mar 2021 • Hui Wang, Wan-Lei Zhao, Xiangxiang Zeng
NN-Descent was proposed as an effective solution for the graph construction problem.
no code implementations • 21 May 2020 • Xiangxiang Zeng, Xiang Song, Tengfei Ma, Xiaoqin Pan, Yadi Zhou, Yuan Hou, Zheng Zhang, George Karypis, Feixiong Cheng
While this study, by no means recommends specific drugs, it demonstrates a powerful deep learning methodology to prioritize existing drugs for further investigation, which holds the potential of accelerating therapeutic development for COVID-19.
no code implementations • 7 Mar 2017 • Quan Zou, Shixiang Wan, Ying Ju, Jijun Tang, Xiangxiang Zeng
TATA-binding protein (TBP) is a kind of DNA binding protein, which plays a key role in the transcription regulation.